DJIA 17,039.49 0.00 0.00%
NASDAQ 4,532.10 0.00 0.00%
S&P 500 1,992.37 0.00 0.00%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog

GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog

3 Dividend Kings From The U.K. I Love To Buy

Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Closing Update: Stocks Scratch Out Small Gains After Fed Minutes Point to Eventual Rate Moves

Sector Update: Health Care Stocks Rebound Late; Amicus Therapeutics Gives Up Much of Wednesday Advan

Sector Update: Health Care Stocks Rebound Late; Amicus Therapeutics Gives Up Much of Wednesday Advance

UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma

Why Mylan (MYL) Stock Is Advancing Today

Eurozone Recovery Stalls in Q2: 3 Stocks to Sell Now - Analyst Blog

3 Reasons GlaxoSmithKline plc Stock Could Rise

GlaxoSmithKline's transition period has been far rougher than expected, causing shares to drop nearly 15% last quarter. Even so, there are three compelling reasons to believe that shares could rally heading into the end of the year.
See More Articles...